Chrome Extension
WeChat Mini Program
Use on ChatGLM
VIPCreated with Sketch.

Patterns of Progression on First Line Osimertinib in Patients with EGFR Mutation-Positive Advanced Non-Small Cell Lung Cancer (NSCLC): A Swiss Cohort Study

A. Schuler,J. Huser,S. Schmid,S. Schar,A. Scherz,O. Gautschi,L. Mauti,T. von Briel,C. Waibel,J. Pankovics,M. T. Mark,S. I. Rothschild,A. Addeo,W. D. Janthur,M. Siano,L. Boos,C. Britschgi,M. Fruh

LUNG CANCER（2024）

Cited 1|Views23
Key words
Osimertinib,Oligo-progression,EGFR mutation,Tyrosine kinase inhibitor,Resistance mechanism
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined